Skip to main content
. 2020 Aug 13;12(8):2271. doi: 10.3390/cancers12082271
ADT Androgen Deprivation Therapy
BCR Biochemical Recurrence
CI Confidence Interval
CRPC Castration-Resistant Prostate Cancer
CT Computed Tomography
EAU European Association of Urology
GTV Gross Tumor Volume
HR Hazard Ratio
ICECAP Intermediate Clinical Endpoints of Cancer of the Prostate
IQR Interquartile Range
ISUP International Society of Urological Pathology
LN Lymph Node
mCRPC Metastatic Castration-Resistant Prostate Cancer
MDT Metastasis-Directed Therapy
NA Not Available
PCa Prostate Cancer
PALN Para-Aortic Lymph Node
PSA Prostate-Specific Antigen
PSMA Prostate Specific Membrane Antigen
PTV Planning Target Volume
RP Radical Prostatectomy
RT Radiotherapy
SBRT Stereotactic Body Radiation Therapy
SIB Simultaneous Integrated Boost
sLND Salvage Lymph Node Dissection/Salvage Lymphadenectomy